GH Research PLC Made Headway
Mon, Feb 03, 2025 at 07:31 PM
GH Research PLC (GHRS:NASDAQ) soared at $17.99, a gain of 69.7%. On Mon, Feb 03, 2025, GHRS:NASDAQ hit a New 2-Week High of $17.99. The stock appeared on our News Catalysts scanner on Mon, Feb 03, 2025 at 06:15 PM in the 'PUBLIC OFFERING' category. From Tue, Jan 21, 2025, the stock recorded 55.56% Up Days and 50.00% Green Days
About GH Research PLC (GHRS:NASDAQ)
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.
Top 10 Gainers:
- Invivyd Inc. (IVVD:NASDAQ), 196.34%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 192.31%
- HCW Biologics Inc. (HCWB:NASDAQ), 128.58%
- MDJM LTD (UOKA:NASDAQ), 83.08%
- GH Research PLC (GHRS:NASDAQ), 69.72%
- Singularity Future Technology Ltd. (SGLY:NASDAQ), 65.34%
- Society Pass Incorporated (SOPA:NASDAQ), 59.87%
- Reborn Coffee Inc. (REBN:NASDAQ), 54.24%
- Calidi Biotherapeutics Inc. (CLDI:NYSEMKT), 38.49%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 35.71%